Using EEG-Guided Basket and Umbrella Trials in Psychiatry: A Precision Medicine Approach for Cognitive Impairment in Schizophrenia

Using EEG-Guided Basket and Umbrella Trials in Psychiatry: A Precision Medicine Approach for Cognitive Impairment in Schizophrenia

Due to advances over the last several decades, many fields of medicine are moving toward a precision medicine approach where treatments are tailored to nuanced patient factors. While in some disciplines these innovations are commonplace leading to unique biomarker-guided experimental medicine trials...

Full description

Bibliographic Details
Main Authors:	Yash B. Joshi, Gregory A. Light
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-11-01
Series:	Frontiers in Psychiatry
Subjects:	schizophrenia mismatch negativity biomarker clinical trial cognitive impairment
Online Access:	https://www.frontiersin.org/article/10.3389/fpsyt.2018.00554/full

Similar Items

Cortical substrates and functional correlates of auditory deviance processing deficits in schizophrenia
by: Anthony J. Rissling, et al.
Published: (2014-01-01)

A Predictive Coding Perspective on Mismatch Negativity Impairment in Schizophrenia
by: Kenji Kirihara, et al.
Published: (2020-07-01)

Neurophysiological Biomarkers in Schizophrenia—P50, Mismatch Negativity, and TMS-EMG and TMS-EEG
by: Helena K. Kim, et al.
Published: (2020-08-01)

Mismatch Negativity and Impaired Social Functioning in Long-Term and in First Episode Schizophrenia Spectrum Psychosis
by: Timothy K. Murphy, et al.
Published: (2020-06-01)

Mice with subtle reduction of NMDA NR1 receptor subunit expression have a selective decrease in mismatch negativity: Implications for schizophrenia prodromal population
by: Robert E. Featherstone, et al.
Published: (2015-01-01)

Mismatch negativity and P3a/reorienting complex in subjects with schizophrenia or at-risk mental state
by: Yuko eHiguchi, et al.
Published: (2014-05-01)

Differential of Frequency and Duration Mismatch Negativity and Theta Power Deficits in First-Episode and Chronic Schizophrenia
by: Yan-Bing Xiong, et al.
Published: (2019-03-01)

Contributions of experimental psychiatry to research on the psychosis prodrome
by: Mitja eBodatsch, et al.
Published: (2013-12-01)

Translatability of Scalp EEG Recordings of Duration-Deviant Mismatch Negativity Between Macaques and Humans: A Pilot Study
by: Mariko Tada, et al.
Published: (2020-08-01)

Screening for cognitive impairment in schizophrenia: Psychometric properties of the German version of the Screen for Cognitive Impairment in Psychiatry (SCIP-G)
by: Gabriele Sachs, et al.
Published: (2021-09-01)

Reductions in Complex Mismatch Negativity to Extra Tone Gestalt Pattern Deviance in First-Episode Schizophrenia
by: Dean F. Salisbury, et al.
Published: (2020-06-01)

Impaired Sensory Processing During Low-Oxygen Exposure: A Noninvasive Approach to Detecting Changes in Cognitive States
by: Todd R. Seech, et al.
Published: (2020-01-01)

Electrophysiological and neuropsychological predictors of conversion to schizophrenia in at-risk subjects
by: Tomiki eSumiyoshi, et al.
Published: (2013-10-01)

Interaction of Background Noise and Auditory Hallucinations on Phonemic Mismatch Negativity (MMN) and P3a Processing in Schizophrenia
by: Ashley M. Francis, et al.
Published: (2020-09-01)

Mismatch Negativity in Patients with Schizophrenia
by: Aleš Urban, et al.
Published: (2007-01-01)

Mismatch Negativity to Threatening Voices associated with Positive Symptoms in Schizophrenia
by: Chenyi Chen, et al.
Published: (2016-07-01)

Nicotine, auditory sensory memory and attention in a human ketamine model of schizophrenia: moderating influence of a hallucinatory trait
by: Verner eKnott, et al.
Published: (2012-09-01)

Predicting subclinical psychotic-like experiences on a continuum using machine learning
by: Jeremy A. Taylor, et al.
Published: (2021-11-01)

Auditory Mismatch Negativity Under Predictive Coding Framework and Its Role in Psychotic Disorders
by: Chun Yuen Fong, et al.
Published: (2020-09-01)

Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study
by: Subodh Kumar, et al.
Published: (2014-01-01)

Effects of Repetitive Transcranial Magnetic Stimulation Treatment on Event-Related Potentials in Schizophrenia
by: Xiao-Dong Lin, et al.
Published: (2018-01-01)

Alpha EEG guided TMS in schizophrenia
by: Yi Jin, et al.
Published: (2012-10-01)

Change in the Neural Response to Auditory Deviance Following Cognitive Therapy for Hallucinations in Patients With Schizophrenia
by: Verner Knott, et al.
Published: (2020-06-01)

Effects of High-Frequency rTMS on Negative Symptoms and Cognitive Function in Hospitalized Patients With Chronic Schizophrenia: A Double-Blind, Sham-Controlled Pilot Trial
by: Na Wen, et al.
Published: (2021-09-01)

Brain structural changes and neuropsychological impairments in male polydipsic schizophrenia
by: Nagashima Tomohisa, et al.
Published: (2012-11-01)

Neurophysiologic Characterization of Resting State Connectivity Abnormalities in Schizophrenia Patients
by: Daisuke Koshiyama, et al.
Published: (2020-11-01)

Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial
by: Zhuo K, et al.
Published: (2019-05-01)

Deficits in Pre-attentive Processing of Spatial Location and Negative Symptoms in Subjects at Clinical High Risk for Schizophrenia
by: Pejman Sehatpour, et al.
Published: (2021-02-01)

Mismatch Negativity in Rat Auditory Cortex Represents the Empirical Salience of Sounds
by: Tomoyo Isoguchi Shiramatsu, et al.
Published: (2018-12-01)

Pervalence of Negative Symptoms in Schizophrenia
by: Saeed Shoja-Shefti, et al.
Published: (2002-10-01)

Cognitive impairment in patients with schizophrenia: A comparative study from western Rajasthan
by: Nikita Dhaka, et al.
Published: (2020-01-01)

EEG/ERP as a pragmatic method to expand the reach of infant-toddler neuroimaging in HBCD: Promises and challenges
by: Elizabeth S. Norton, et al.
Published: (2021-10-01)

Subjectively-assessed cognitive impairment and neurocognition associations in schizophrenia inpatients
by: Tatsuhiko Masuzawa, et al.
Published: (2022-03-01)

Mismatch negativity (MMN) latency as a biomarker of amnestic mild cognitive impairment in Chinese rural elders
by: Li li Ji, et al.
Published: (2015-03-01)

Effect of EEG Referencing Methods on Auditory Mismatch Negativity
by: Yatin Mahajan, et al.
Published: (2017-10-01)

Negative symptoms in schizophrenia
by: Sayantanava Mitra, et al.
Published: (2016-01-01)

Neurophysiological biomarkers for schizophrenia therapeutics
by: Gregory A. Light, et al.
Published: (2020-06-01)

Cariprazine: Patients with Treatment-Resistant Schizophrenia
by: Aubel T
Published: (2021-07-01)

Optimizing Behavioral Paradigms to Facilitate Development of New Treatments for Anhedonia and Reward Processing Deficits in Schizophrenia and Major Depressive Disorder: Study Protocol
by: Amy C. Bilderbeck, et al.
Published: (2020-11-01)

Increased Plasma Kynurenic Acid Levels are Associated with Impaired Attention/Vigilance and Social Cognition in Patients with Schizophrenia
by: Huang X, et al.
Published: (2020-01-01)